TwitterRSSFacebookDirectors Blog
  Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

Funding News - HLA Region Genomics in Immune-Mediated Diseases

Archive folder iconHistorical Data

  • The information on this page is for historical and research purposes only.
  • For the most current NINDS funding announcements, please see the NINDS list of Active Funding Initiatives or Follow Us on Twitter for the latest funding news.

NINDS and the National Institute of Allergy and Infectious Diseases (NIAID) request applications to participate in the HLA Region Genomics in Immune-Mediated Diseases Consortium.

The consortium is a cooperative research group whose goals are to define and catalog the association between variations in human leukocyte antigen (HLA) and natural killer cell immunoglobulin-like receptor (KIR) genetic regions and immune-mediated diseases, including risk and severity of disease, and organ, tissue, and cell transplantation outcomes. Identifying and defining the role of specific HLA-region and KIR-region gene variations in disease susceptibility or protection, progression, and severity will allow clinicians to predict disease risk and to develop targeted treatments and/or preemptive strategies. 

Application Receipt Date:  November 19, 2009

Potential applicants should contact Dr. Ursula Utz, program director, Neural Environment Cluster, NINDS; telephone: 301-496-1431; email:  For more information visit